Primecap Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$432K Hold
340,418
﹤0.01% 313
2025
Q4
$814K Sell
340,418
-1,028,649
-75% -$2.81M ﹤0.01% 311
2025
Q3
$3.9M Sell
1,369,067
-617,620
-31% -$2.11M ﹤0.01% 286
2025
Q2
$7.49M Sell
1,986,687
-18,429
-0.9% -$72.5K 0.01% 273
2025
Q1
$9.08M Buy
2,005,116
+72,499
+4% +$384K 0.01% 259
2024
Q4
$13.7M Sell
1,932,617
-471,845
-20% -$3.76M 0.01% 245
2024
Q3
$19.6M Buy
2,404,462
+25,000
+1% +$181K 0.01% 233
2024
Q2
$15.2M Buy
2,379,462
+305,079
+15% +$1.96M 0.01% 239
2024
Q1
$15.6M Buy
2,074,383
+654,806
+46% +$5.98M 0.01% 241
2023
Q4
$13.1M Buy
1,419,577
+299,139
+27% +$2.44M 0.01% 250
2023
Q3
$11.3M Buy
1,120,438
+519,004
+86% +$6.2M 0.01% 251
2023
Q2
$7.52M Buy
601,434
+11,100
+2% +$132K 0.01% 268
2023
Q1
$6.89M Buy
590,334
+119,000
+25% +$1.52M 0.01% 270
2022
Q4
$5.01M Sell
471,334
-910
-0.2% -$8.79K ﹤0.01% 275
2022
Q3
$4.58M Buy
472,244
+166,000
+54% +$2.2M ﹤0.01% 277
2022
Q2
$4.44M Buy
306,244
+34,717
+13% +$592K ﹤0.01% 288
2022
Q1
$7.09M Buy
271,527
+31,283
+13% +$888K 0.01% 276
2021
Q4
$9.52M Buy
240,244
+7,335
+3% +$334K 0.01% 266
2021
Q3
$11.6M Sell
232,909
-106
-0% -$5.78K 0.01% 261
2021
Q2
$12.9M Buy
233,015
+11,000
+5% +$586K 0.01% 254
2021
Q1
$10.4M Buy
222,015
+121,106
+120% +$5.87M 0.01% 263
2020
Q4
$4.39M Buy
100,909
+36,000
+55% +$1.33M ﹤0.01% 279
2020
Q3
$2.38M Buy
64,909
+20,000
+45% +$679K ﹤0.01% 279
2020
Q2
$1.31M Buy
+44,909
New +$1.24M ﹤0.01% 287

Other funds holding HCAT